45.68 1.28 (2.88%) | 05-22 14:53 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 68.38 | 1-year : | 82.06 |
Resists | First : | 58.55 | Second : | 70.26 |
Pivot price | 43.72 ![]() |
|||
Supports | First : | 39.6 | Second : | 32.95 |
MAs | MA(5) : | 44.11 ![]() |
MA(20) : | 49.45 ![]() |
MA(100) : | 46.33 ![]() |
MA(250) : | 35.84 ![]() |
|
MACD | MACD : | -3.2 ![]() |
Signal : | -3 ![]() |
%K %D | K(14,3) : | 19.8 ![]() |
D(3) : | 16.2 ![]() |
RSI | RSI(14): 42.7 ![]() |
|||
52-week | High : | 70.26 | Low : | 16.84 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PDEX ] has closed below upper band by 20.9%. Bollinger Bands are 67.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 45.86 - 46.09 | 46.09 - 46.27 |
Low: | 43.83 - 44.07 | 44.07 - 44.26 |
Close: | 44.02 - 44.42 | 44.42 - 44.73 |
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Wed, 14 May 2025
Dimensional Fund Advisors LP Decreases Stock Holdings in Pro-Dex, Inc. (NASDAQ:PDEX) - Defense World
Mon, 05 May 2025
Pro-Dex: Crash After Strong Earnings Leads To A Buying Opportunity (NASDAQ:PDEX) - Seeking Alpha
Sun, 04 May 2025
Here's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of Investors - Yahoo Finance
Thu, 01 May 2025
Pro-Dex, Inc. Reports Strong Quarterly Earnings Growth - TipRanks
Thu, 01 May 2025
Pro-Dex, Inc. (PDEX) Q3 Earnings Surpass Estimates - Yahoo Finance
Fri, 25 Apr 2025
ProDex (PDEX) Moves 5.1% Higher: Will This Strength Last? - Nasdaq
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Instruments & Supplies
|
|
Shares Out | 3 (M) |
Shares Float | 2 (M) |
Held by Insiders | 35.9 (%) |
Held by Institutions | 30.8 (%) |
Shares Short | 126 (K) |
Shares Short P.Month | 62 (K) |
EPS | 2.75 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 10.81 |
Profit Margin | 14.6 % |
Operating Margin | 20.8 % |
Return on Assets (ttm) | 12.7 % |
Return on Equity (ttm) | 28.2 % |
Qtrly Rev. Growth | 21.7 % |
Gross Profit (p.s.) | 6.16 |
Sales Per Share | 19.66 |
EBITDA (p.s.) | 3.96 |
Qtrly Earnings Growth | 416.3 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -1 (M) |
PE Ratio | 16.4 |
PEG Ratio | 0 |
Price to Book value | 4.18 |
Price to Sales | 2.3 |
Price to Cash Flow | -301.84 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |